{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:58:03Z","timestamp":1783979883212,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The burden of female genital tract cancers in low\u2014and middle-income countries (LIMC) is not yet well investigated. Although available studies are few, they are mainly based on single institutions. Here, four-year multi-institutional data on gynecologic cancers in northeastern Nigeria were examined to determine their distribution by age and subtype.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient and Methods<\/jats:title><jats:p>This is a cross-sectional descriptive study using available data on histologically diagnosed gynecologic cancers archived in the pathology departments and\/or cancer registries of six tertiary hospitals in northeastern Nigeria over four years. Alongside tumor type (according to site), patient age and presenting complaints were also documented. Descriptive statistics were used to present categorical variables as proportions, while quantitative variables of age were presented as medians.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 863 gynecologic cancers were included in this study. The median age was 50 years (3 \u2013 95 years) with a peak at 40 \u2013 49 years. The uterine cervix was the most common site of cancer (66.6%, 575\/863), while uterine corpus (15.5%, 134\/863) and ovarian cancers (14.8%; 128\/863) were nearly equal in proportion. Squamous cell cancer was the commonest histotype overall, while ovarian cancers had a preponderance of epithelial tumors in 67.9% (87\/128) over sex cord stromal (12.5%; 16\/128) and germ cell (9.4%, 12\/128) tumors. The most common symptom was abnormal vaginal bleeding (38%) followed by abdominal swelling (21.1%) and foul-smelling vaginal discharge (14.1%). Population-based data also showed high parity among women in the region, ranging from 4 births to 7 births per woman in a reproductive lifetime (total fertility rate, TFR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The spectrum of cancers of the female genital tract in this study mirrors the population demographics characterized by a high proportion of young women in their reproductive age. Efforts to reduce the burden of this disease are urgently warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1420113","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:58:52Z","timestamp":1742281132000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Spectrum of gynecologic malignancies in Northeastern Nigeria"],"prefix":"10.3389","volume":"15","author":[{"given":"Dauda A.","family":"Katagum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uchenna S.","family":"Ezenkwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunday E.","family":"Achanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliyu I.","family":"Lawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dauda E.","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairo U.","family":"Kadaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abba","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamu I.","family":"Adamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar Kolomi","family":"Modu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadiza","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia H. L.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Schlumbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala M.","family":"Audu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"04155","DOI":"10.7189\/jogh.14.04155","article-title":"Global burden of gynecological cancers in 2022 and projections to 2050","volume":"14","author":"Zhu","year":"2024","journal-title":"J Glob Health"},{"key":"B2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/IJCN.IJCN_3_19","article-title":"Gynecological cancers","volume":"20","author":"David","year":"2019","journal-title":"Indian J Contin Nurs Educ"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.06.05?viewType=HTML","article-title":"Cervical cancer: Epidemiology, risk factors and screening","volume":"32","author":"Zhang","year":"2020","journal-title":"Chin J Cancer Res"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.4103\/apjon.apjon_73_18","article-title":"Risk factors of cervical cancer: A case-control study","volume":"6","author":"Kashyap","year":"2019","journal-title":"Asia-Pac J Oncol Nurs"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1097\/EDE.0000000000000434","article-title":"The association between talc use and ovarian cancer: A retrospective case\u2013control study in two US states","volume":"27","author":"Cramer","year":"2016","journal-title":"Epidemiology"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer: An umbrella review of the literature","volume":"145","author":"Raglan","year":"2019","journal-title":"Int J Cancer"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1016\/j.gyobfe.2014.09.013","article-title":"How women with gynecological cancer deal with treatment: Issues of visibility and invisibility","volume":"42","author":"Giacomoni","year":"2014","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertil"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2017.ed62","article-title":"Psychological impact of fertility preservation techniques in women with gynecological cancer","volume":"11","author":"Lagan\u00e0","year":"2017","journal-title":"ecancermedicalscience"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e52","article-title":"Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007\u20132014","volume":"31","author":"Yue","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"B11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3329\/seajph.v7i1.34672","article-title":"Major Public Health Problems in Nigeria: A review","volume":"7","author":"Muhammad","year":"2017","journal-title":"South East Asia J Public Health"},{"key":"B12","first-page":"5","article-title":"The war against non-communicable disease: how ready is Nigeria","volume":"15","author":"Olukoya","year":"2017","journal-title":"Ann Ib Postgrad Med"},{"key":"B13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/2278-960X.161046","article-title":"Frequency and pattern of gynecological cancers in federal teaching hospital, Abakaliki, Nigeria","volume":"4","author":"Joseph","year":"2015","journal-title":"J Basic Clin Reprod Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.11604\/pamj.2023.44.139.39034","article-title":"Profile of gynecological cancers in a tertiary hospital, Eastern Nigeria","volume":"44","author":"Nzeribe","year":"2023","journal-title":"Pan Afr Med J"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2024.1750","article-title":"A histopathological review of gynecological Malignancies in Katsina state North-Western Nigeria","volume":"18","author":"Usman","year":"2024","journal-title":"ecancermedicalscience"},{"key":"B16","volume-title":"National Population Commission Nigeria 2020","author":"Oyetunji","year":"2020"},{"key":"B17","article-title":"Female genital tumors","volume-title":"WHO Classification of Tumors","year":"2020"},{"key":"B18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B20","article-title":"Pattern of gynecological Malignancies iat a university teaching hospital in Southwest Nigeria: A 5-year review","volume":"63","author":"Okunade","year":"2022","journal-title":"Niger Med J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-004213","article-title":"The European Society of Gynecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia","volume":"33","author":"Kesic","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.883805\/full","article-title":"A comprehensive discussion in vaginal cancer based on mechanisms, treatments, risk factors and prevention","volume":"12","author":"Baral","year":"2022","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.3390\/cancers14174184","article-title":"Management of early-stage vulvar cancer","volume":"14","author":"Pedr\u00e3o","year":"2022","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ygyno.2017.02.030","article-title":"Epidemiology of vulvar neoplasia in the NIH-AARP Study","volume":"145","author":"Brinton","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ijgo.13867","article-title":"Cancer of the vagina: 2021 update","volume":"155","author":"Adams","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150033","article-title":"Primary vaginal cancer: role of MRI in diagnosis, staging and treatment","volume":"88","author":"Gardner","year":"2015","journal-title":"Br J Radiol"},{"key":"B27","first-page":"291","article-title":"Squamous precursor lesions of the vulva: current classification and diagnostic challenges","volume":"48","author":"Hoang","year":"2016","journal-title":"Pathol (Phila)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088323","article-title":"Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance","volume":"9","author":"Nyg\u00e5rd","year":"2014","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00151","article-title":"Human papilloma virus distribution across the African diaspora","volume":"7","author":"Jeudin","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/03008916231208344","article-title":"HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination","volume":"110","author":"Bogani","year":"2024","journal-title":"Tumori J"},{"key":"B31","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.21873\/anticanres.11072","article-title":"Non-epithelial ovarian cancer: elucidating uncommon gynecological Malignancies","volume":"36","author":"Boussios","year":"2016","journal-title":"Anticancer Res"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/6734031","article-title":"Uterine cancer mortality in white and African American females in Southeastern North Carolina","volume":"2020","author":"Kravchenko","year":"2020","journal-title":"J Environ Public Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004710","article-title":"Health disparities in uterine cancer: report from the uterine cancer evidence review conference","volume":"139","author":"Whetstone","year":"2022","journal-title":"Obstet Gynecol"},{"key":"B35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajog.2022.07.040","article-title":"African ancestry is associated with aggressive endometrial cancer","volume":"228","author":"Sanchez-Covarrubias","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/10732748231202952","article-title":"Unique considerations in early detection, risk, and awareness of endometrial cancer in black women","volume":"30","author":"Schlumbrecht","year":"2023","journal-title":"Cancer Control"},{"key":"B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/oalib.1109923","article-title":"Epidemiology of gestational choriocarcinoma: A systematic review","volume":"10","author":"Amalina","year":"2023","journal-title":"OALib"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4236\/ojog.2015.56048","article-title":"Delayed presentation of patients with gynecological Malignancies in Kano, North-Western Nigeria","volume":"5","author":"Adamou","year":"2015","journal-title":"Open J Obstet Gynecol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.18203\/2320-1770.ijrcog20201776","article-title":"Gynecological Malignancies in Azare, North-East Nigeria: an assessment of types, stage at presentation and treatment affordability","volume":"9","author":"Aminu","year":"2020","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2014.09.034","article-title":"Coverage and distribution of obstetricians and gynecologists in Nigeria","volume":"129","author":"Agboghoroma","year":"2015","journal-title":"Int J Gynecol Obstet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4236\/ojog.2013.38115","article-title":"The burden of gynecological cancer management in Northern Nigeria","volume":"3","author":"Oguntayo","year":"2013","journal-title":"Open J Obstet Gynecol"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1097","article-title":"Radiotherapy waiting time in Northern Nigeria: experience from a resource-limited setting","volume":"14","author":"Tumba","year":"2020","journal-title":"ecancermedicalscience"},{"key":"B43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12905-016-0306-6","article-title":"Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective","volume":"16","author":"Finocchario-Kessler","year":"2016","journal-title":"BMC Womens Health"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1420113\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:59:00Z","timestamp":1742281140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1420113\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":43,"alternative-id":["10.3389\/fonc.2025.1420113"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1420113","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"article-number":"1420113"}}